Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyRalf Reilmann, Hope Heller, Beth Borowsky et al.|The Lancet Neurology|2018Cited by 108
Molecular genetics in the National Health Service in Britain.R Harris, Andrew Read, R Elles et al.|Journal of Medical Genetics|1989Cited by 19